CLCR Call: March 30, 2020

For Public Health

At a glance

The March 30, 2020, Clinical Laboratory COVID-19 Response (CLCR) call included updates on serology testing, emergency use authorizations, CLIA guidance, surveillance, and biosafety.

Format: MP3
Language: English (US)
Size: 36 MB

Agenda

Archived LOCS Materials Access

Contact LOCS to access archived LOCS materials.

Welcome and Introductions: Jasmine Chaitram, CDC Division of Laboratory Systems

Serology Testing, Updated Testing Guidance, Nasal Swabs: Wendi Kuhnert-Tallman, CDC Laboratory Task Force

Emergency Use Authorizations (EUAs) for Serology Tests and At-Home/Self-Collection Tests: Tim Stenzel, U.S. Food and Drug Administration (FDA)

New CLIA Guidance and Validating Tests for Laboratories Responding to COVID-19: Karen Dyer, Centers for Medicare & Medicaid Services (CMS)

Supporting Epidemiologic and Surveillance Needs: Janet Hamilton, Council of State and Territorial Epidemiologists (CSTE)

Laboratory Biosafety Update: Bill Arndt, CDC Division of Laboratory Systems

Meeting materials


Content Source
About this page
Published: November 20, 2024
Updated: March 30, 2020

This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.

Reviewed: March 30, 2020

The information on this page was last reviewed by subject matter experts to ensure accuracy.